DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CROMOLYN SODIUM

« Back to Dashboard

Clinical Trials for Cromolyn Sodium

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000575	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	CAMP Steering Committee	Phase 3	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 3	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000577	Asthma Clinical Research Network (ACRN)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00000622	Childhood Asthma Research and Education (CARE) Network	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	The purpose of this study is to evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.

Clinical Trial Conditions for Cromolyn Sodium

Condition Name

Condition Name for Cromolyn Sodium
Intervention	Trials
Asthma	7
Lung Diseases	5
Bronchial Asthma	3
Ischemic Stroke	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cromolyn Sodium
Intervention	Trials
Asthma	10
Lung Diseases	5
Esophagitis	2
Eosinophilic Esophagitis	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cromolyn Sodium

Trials by Country

Trials by Country for Cromolyn Sodium
Location	Trials
United States	17
Poland	3
Ukraine	3
France	1
Netherlands	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cromolyn Sodium
Location	Trials
California	6
Wisconsin	2
Missouri	2
Colorado	2
Tennessee	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cromolyn Sodium

Clinical Trial Phase

Clinical Trial Phase for Cromolyn Sodium
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	7
Phase 2	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cromolyn Sodium
Clinical Trial Phase	Trials
Completed	14
Recruiting	2
Unknown status	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cromolyn Sodium

Sponsor Name

Sponsor Name for Cromolyn Sodium
Sponsor	Trials
National Heart, Lung, and Blood Institute (NHLBI)	6
Chiesi Farmaceutici S.p.A.	3
Childhood Asthma Research and Education Network	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cromolyn Sodium
Sponsor	Trials
Other	16
NIH	8
Industry	7

Export unavailable in trial.
Subscribe for complete access.